Exploring reasons for overuse of contralateral prophylactic mastectomy in Canada.
Contralateral prophylactic mastectomy
behaviour change
breast cancer
implementation
knowledge translation
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
entrez:
25
9
2019
pubmed:
25
9
2019
medline:
15
5
2020
Statut:
ppublish
Résumé
Contralateral prophylactic mastectomy (cpm) in women with known unilateral breast cancer (bca) has been increasing despite the lack of supportive evidence. The purpose of the present study was to identify the determinants of cpm in women with unilateral bca. This qualitative descriptive study used semi-structured interviews informed by the Theoretical Domains Framework. We interviewed 74 key informants (surgical oncologists, plastic surgeons, medical oncologists, radiation oncologists, nurses, women with bca) across Canada. Interviews were analyzed using thematic analysis and an analysis for shared and discipline-specific beliefs. In total, 58 factors influencing the use of cpm were identified: 26 factors shared by various health care professional groups, 15 discipline-specific factors (identified by a single health care professional group), and 17 factors shared by women with unilateral bca. Health care professionals identified more factors discouraging the use of cpm ( Multiple factors discouraging and encouraging the use of cpm in unilateral bca were identified. Those factors identify potential individual, team, organization, and system targets for behaviour change interventions to reduce cpm.
Sections du résumé
Background
Contralateral prophylactic mastectomy (cpm) in women with known unilateral breast cancer (bca) has been increasing despite the lack of supportive evidence. The purpose of the present study was to identify the determinants of cpm in women with unilateral bca.
Methods
This qualitative descriptive study used semi-structured interviews informed by the Theoretical Domains Framework. We interviewed 74 key informants (surgical oncologists, plastic surgeons, medical oncologists, radiation oncologists, nurses, women with bca) across Canada. Interviews were analyzed using thematic analysis and an analysis for shared and discipline-specific beliefs.
Results
In total, 58 factors influencing the use of cpm were identified: 26 factors shared by various health care professional groups, 15 discipline-specific factors (identified by a single health care professional group), and 17 factors shared by women with unilateral bca. Health care professionals identified more factors discouraging the use of cpm (
Conclusions
Multiple factors discouraging and encouraging the use of cpm in unilateral bca were identified. Those factors identify potential individual, team, organization, and system targets for behaviour change interventions to reduce cpm.
Identifiants
pubmed: 31548812
doi: 10.3747/co.26.4951
pii: conc-26-e439
pmc: PMC6726273
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e439-e457Déclaration de conflit d'intérêts
CONFLICT OF INTEREST DISCLOSURES We have read and understood Current Oncology’s policy on disclosing conflicts of interest, and we declare that we have none.
Références
Ann Surg. 2014 Dec;260(6):1000-10
pubmed: 24950272
Ann Surg Oncol. 2016 Oct;23(10):3100-5
pubmed: 27469117
Ann Surg Oncol. 2007 Sep;14(9):2425-7
pubmed: 17597344
Am J Clin Oncol. 2015 Apr;38(2):179-83
pubmed: 23648435
Ann Surg Oncol. 2010 Oct;17(10):2554-62
pubmed: 20461470
Oncologist. 2011;16(7):935-41
pubmed: 21672945
J Am Coll Surg. 2014 Jul;219(1):19-28
pubmed: 24862886
Breast. 2011 Oct;20 Suppl 3:S108-10
pubmed: 22015275
J Clin Oncol. 2006 Mar 20;24(9):1350-6
pubmed: 16549829
J Clin Oncol. 2007 Nov 20;25(33):5203-9
pubmed: 17954711
Implement Sci. 2012 Jun 09;7:52
pubmed: 22682612
Am J Surg. 2000 Dec;180(6):439-45
pubmed: 11182394
JAMA. 2013 Aug 28;310(8):793-4
pubmed: 23907558
Ann Surg Oncol. 2015 Feb;22(2):383-91
pubmed: 25190120
Ann Surg Oncol. 1999 Sep;6(6):546-52
pubmed: 10493622
Ann Surg Oncol. 2010 Oct;17 Suppl 3:230-2
pubmed: 20853038
Ann Surg Oncol. 2013 Oct;20(11):3422-9
pubmed: 23720070
Surgeon. 2014 Dec;12(6):316-22
pubmed: 24685410
Ann Surg Oncol. 2014 Oct;21(10):3173-84
pubmed: 25081340
Implement Sci. 2012 Sep 21;7:93
pubmed: 22999460
Ann Surg Oncol. 2017 Jan;24(1):1-2
pubmed: 27783164
Curr Oncol. 2019 Apr;26(2):137-148
pubmed: 31043816
Ann Surg. 2018 Feb;267(2):271-279
pubmed: 28594745
Lancet Oncol. 2013 Jun;14(7):e262-9
pubmed: 23725708
Qual Saf Health Care. 2005 Feb;14(1):26-33
pubmed: 15692000
Cochrane Database Syst Rev. 2010 Nov 10;(11):CD002748
pubmed: 21069671
J Clin Oncol. 2009 Mar 20;27(9):1362-7
pubmed: 19224844
Ann Intern Med. 2005 Sep 6;143(5):355-61
pubmed: 16144894
Implement Sci. 2012 Apr 24;7:37
pubmed: 22530986
JAMA Surg. 2017 Jul 1;152(7):658-664
pubmed: 28384687
Ann Surg Oncol. 2013 Oct;20(10):3212-7
pubmed: 23846780
Ann Surg Oncol. 2009 Oct;16(10):2682-90
pubmed: 19653046